Publication Cover
Stress
The International Journal on the Biology of Stress
Volume 15, 2012 - Issue 1
1,007
Views
28
CrossRef citations to date
0
Altmetric
Original Research Reports

Effects of dehydroepiandrosterone supplementation during stressful military training: A randomized, controlled, double-blind field study

, , , , , & show all
Pages 85-96 | Received 12 Oct 2010, Accepted 11 Feb 2011, Published online: 26 Jul 2011

References

  • Alhaj HA, Massey AE, McAllistair-Williams RH. 2006. Effects of DHEA administration on episodic memory, cortisol and mood in healthy young men: A double-blind, placebo controlled study. Psychopharmacology. 188:541–551.
  • Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel M, Ernst M, Schulte HM, Allolio B. 1999. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med. 341:1013–1020.
  • Arlt W, Callies F, Allolio B. 2000. DHEA replacement in women with adrenal insufficiency: Pharmocokinetics, bioconversion and clinical effects on well-being, sexuality, and cognition. Endocr Res. 26:505–511.
  • Assies J, Visser I, Nicolson NA, Eggelte TA, Wekking EM, Huyser J, Lieverse R, Shene AH. 2004. Elevated salivary dehydroepiandrosterone-sulfate but normal cortisol levels in medicated depressed patients: Preliminary findings. Psychiatry Res. 128:117–122.
  • Barnhart KT, Freeman E, Grisso JA, Rader DJ, Sammel M, Kapoor S, Nestler JE. 1999. The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters and health-related quality of life. J Clin Endocrinol Metab. 84:3896–3902.
  • Barrett-Connor E, von Muhlen D, Laughlin GA, Kripke A. 1999. Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones are associated with depressed mood in older women: The Rancho Bernardo Story. J Am Geriatr Soc. 47:685–691.
  • Bastianetto S, Ramassamy C, Poirier J, Quiron R. 1999. Dehydroepiandronsterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res Mol Brain Res. 66:35–41.
  • Baulieu EE, Robel P. 1998. Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids. Proc Natl Acad Sci U S A. 95:4089–4091.
  • Baulieu EE, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B, Faucounau V, Girard L, Hervy MP, Latour F, Leaud MC, Mokrane A, Pitti-Ferrandi H, Trivalle C, de Lacharriere O, Nouveau S, Rakoto-Arison B, Souberbielle JC, Raison J, Le Bouc Y, Raynaud A, Giered X, Forette F. 2000. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: Contribution of the DHEAge study to a sociobiomedical issue. Proc Natl Acad Sci U S A. 97:4279–4284.
  • Bernardi F, Lanzone A, Cento RM, Spada RS, Pezzani I, Genazzani AD, Luisi S, Luisi M, Petraglia G, Genazzani AR. 2000. Allopregnenolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia. Eur J Endocrinol. 142:466–471.
  • Bologa L, Sharma J, Roberts E. 1987. Dehydroepiandrosterone and its sulfated derivative reduce neuronal death and enhance astrocytic differentiation in brain cell cultures. J Neurosci Res. 17:225–234.
  • Boscarino JA. 2008. A prospective study of PTSD and early-age heart disease mortality among Vietnam veterans: Implications for surveillance and prevention. Psychosom Med. 70:668–676.
  • Bremner JD. Stress and brain atrophy. CNS Neurol Disord Drug Targets. 2006a; 5:503–512.
  • Bremner JD. Traumatic stress: Effects on the brain. Dialogues Clin Neurosci. 2006b; 8:445–461.
  • Bremner JD, Krystal JH, Putman FW, Southwick SM, Marmar C, Charney DS, Mazure CM. 1998. Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS). J Trauma Stress. 11:125–136.
  • Butterfield MI, Stechuchak KM, Connor KM, Davidson JR, Wang C, MacKuen CL, Pearlstein AM, Marx CE. 2005. Neuroactive steroids and suicidality in posttraumatic stress disorder. Am J Psychiatry. 162:380–382.
  • Cardounel A, Regelson W, Kalimi M. 1999. Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: Mechanism of action. Proc Soc Exp Biol Med. 222:145–149.
  • Carvalhaes-Neto N, Huayllas MK, Ramos LR, Cendoroglo MS, Kater CE. 2003. Cortisol, DHEAS, and aging: Resistance to cortisol suppression in frail institutionalized elderly. J Endocrinol Invest. 26:17–22.
  • Chen CC, Parker CRJr. 2004. Adrenal androgens and the immune system. Semin Reprod Med. 22:369–377.
  • Chichinadze K, Chichinadze N. 2008. Stress-induced increase of testosterone: Contributions of social status and sympathetic reactivity. Physiol Behav. 94:595–603.
  • Compagnone NA, Mellon SH. 1998. Dehydroepiandronsterone: A potential signaling molecule for neurocortical organization during development. Proc Natl Acad Sci U S A. 95:4678–4683.
  • Deuster PA, Faraday MM, Chrousos GP, Poth MA. 2005. Effects of dehydroepiandrosterone and alprazolam on hypothalamic–pituitary responses to exercise. J Clin Endocrinol Metab. 90:4777–4783.
  • Eid J, Morgan C. 2006. Dissociation, hardiness, and performance in military cadets participating in survival training. Mil Med. 171:436–442.
  • Eser D, Schule C, Romeo E, Baghai TC, di Michele F, Pasini A, Zwanzger P, Padberg F, Rupprecht R. 2006. Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders. Psychopharmacology (Berl). 186:373–387.
  • Fava M, Rosenbaum JF, MacLaughlin RA, Tesar GE, Pollack MH, Cohen LS, Hirsch M. 1989. Dehydroepiandrosterone-sulfate/cortisol ratio in panic disorder. Psychiatry Res. 28:345–350.
  • Fiore C, Inman DM, Hirose S, Noble LJ, Igarashi T, Compagnone NA. 2004. Treatment with the neurosteroid dehydroepiandrosterone promotes recovery of motor behavior after moderate contusive spinal cord injury in the mouse. J Neurosci Res. 75:391–400.
  • Friess E, Schiffelholz T, Steckler T, Steiger A. 2000. Dehydroepiandrosterone: A neurosteroid. Eur J Clin Invest. 30:46–50.
  • Gomez-Merino D, Drogou C, Chennaoui M, Tiollier E, Mathieu J, Guezzennec CY. 2005. Effects of combined stress during intense training on cellular immunity, hormones and respiratory infections. Neuroimmunomodulation. 12:164–172.
  • Goodyer IM, Herbert J, Altham PM. 1998. Adrenal steroid secretion and major depression in 8- to 16-year-olds, III. Influence of cortisol/DHEA ratio at presentation on subsequent rates of disappointing life events and persistent major depression. Psychol Med. 28:265–273.
  • Granger DA, Kivlighan KT, Fortunato C, Harmon AG, Hibel LC, Schwartz EB, Whembolua GL. 2007. Integration of salivary biomarkers into developmental and behaviorally-oriented research: Problems and solutions for collecting specimens. Physiol Behav. 92 4: 583–590.
  • Hardy MP, Gao HB, Dong Q, Wang Q, Chai WR, Feng X, Sottas C. 2005. Stress hormone and male reproductive function. Cell Tissue Res. 322:147–153.
  • Hu Y, Cardounel A, Gursoy E, Anderson P, Kalimi M. 2000. Anti-stress effects of dehydroepiandrosterone: Protection of rats against repeated immobilization stress-induced weight loss, glucocorticoid receptor production, and lipid peroxidation. Biochem Pharmacol. 59:753–762.
  • Kaasik A, Kalda A, Jaako K, Zharkovsky A. 2001. Dehydroepiandrosterone sulphate prevents oxygen–glucose deprivation-induced injury in cerebellar granule cell culture. Neuroscience. 102:427–432.
  • Kaminska M, Harris J, Gijsbers K, Dubrovsky B. 2000. Dehydroepiandrosterone sulfate (DHEAS) counteracts decremental effects of corticosterone on dentate gyrus LTP. Implications for depression. Brain Res Bull. 52:229–234.
  • Karishma KK, Herbert J. 2002. Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur J Neurosci. 16:445–453.
  • Kimonides VG, Spillantini MG, Sofroniew MV, Fawcett JW, Herbert J. 1999. Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase 3 in hippocampal primary cultures. Neuroscience. 89:429–436.
  • Kudielka BM, Hellhammer J, Hellhammer DH, Wolf OT, Pirke KM, Varadi E, Pilz J, Kirschbaum C. 1998. Sex differences in endocrine and psychological responses to psychosocial stress in healthy elderly subjects and the impact of a 2-week dehydroepiandrosterone treatment. J Clin Endocrinol Metab. 83:1756–1761.
  • Labrie F, Diamond P, Cusan L, Gomez JL, Belanger A, Candas B. 1997. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab. 82:3498–3505.
  • Leech NL, Barrett KC, Morgan GA. 2001. SPSS for intermediate statistics. New York: Routledge.
  • Maninger N, Wolkowitz OM, Reus VI, Epel ES, Mellon SH. 2009. Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS). Front Neuroendocrinol. 30:65–91.
  • Maninger N, Capitanio JP, Mason WA, Ruys JD, Mendoza SP. 2010. Acute and chronic stress increase DHEAS concentrations in rhesus monkeys. Psychoneuroendocrinology. 35:1055–1062.
  • Mason JW. 1968. Organization of psychoendocrine mechanisms. Psychosom Med. 30:565–808.
  • Morales AJ, Nolan JJ, Nelson JC, Yen SS. 1994. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab. 78:1360–1367.
  • Morgan CAIII, Wang S, Mason J, Southwick SM, Fox P, Hazlett G, Charney DS, Greenfield G. 2000. Hormone profiles in humans experiencing military survival training. Biol Psychiatry. 47:891–901.
  • Morgan CAIII, Southwick S, Hazlett G, Rasmusson A, Hoyt G, Zimolo Z, Charney D. 2004. Relationships among plasma dehydroepiandrosterone sulfate and cortisol levels, symptoms of dissociation, and objective performance in humans exposed to acute stress. Arch Gen Psychiatry. 61:819–825.
  • Morgan CAIII, Rasmusson A, Pietrzak RH, Coric V, Southwick SM. 2009. Relationships among plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate, cortisol, symptoms of dissociation, and objective performance in humans exposed to underwater navigation stress. Biol Psychiatry. 66:334–340.
  • Morsink LF, Vogelzangs N, Nicklas BJ, Beekman AT, Satterfield S, Rubin SM, Yaffe K, Simonsick E, Newman AB, Kritchevsky SB, Penninx BW, Health ABC Study. 2007. Associations between sex steroid hormone levels and depressive symptoms in elderly men and women: Results from the Health ABC study. Psychoneuroendocrinology. 32:874–883.
  • Nair KS, Rizza RA, O'Brien P, Dhatariya K, Short KR, Nehra A, Vittone JL, Klee GG, Basu A, Basu R, Cobelli C, Toffolo G, Dalla Man C, Tindall DJ, Melton LJ 3rd, Smith GE, Khosla S, Jensen MD. 2006. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med. 355:1647–1659.
  • Nindl BC, Barnes BR, Alemany JA, Frykman PN, Shippee RL, Friedl KE. 2007. Physiological consequences of US army ranger training. Med Sci Sports Exerc. 39:1380–1387.
  • O'Keefe DJ. 2007. Post hoc power, observed power, a priori power, retrospective power, prospective power, achieved power: Sorting out appropriate uses of statistical power analyses. Commun Methods Meas. 1:291–299.
  • Opstad PK. 1992. Androgenic hormones during prolonged physical stress, sleep, and energy deficiency. J Clin Endocrinol Metab. 74:1176–1183.
  • Pico-Alfonso MA, Garcia-Linares MI, Celda-Navarro N, Herbert J, Martinez M. 2004. Changes in cortisol and dehydroepiandrosterone in women victims of physical and psychological intimate partner violence. Biol Psychiatry. 56:233–240.
  • Pierorazio PM, Ferruci L, Kettermann A, Longo DL, Metter EJ, Carter HB. 2010. Serum testosterone is associated with aggressive prostate cancer in older men: Results from the Baltimore Longitudinal Study of Aging. BJU Int. 105:824–829.
  • Rasmusson AM, Vasek J, Lipschitz DS, Vojvoda D, Mustone ME, Shi Q, Gudmundsen G, Morgan CA, Wolfe J, Charney DS. 2004. An increased capacity for adrenal DHEA release is associated with decreased avoidance and negative mood in women with PTSD. Neuropsychopharmacology. 29:1546–1557.
  • Ritsner MS, Gibel A, Ratner Y, Tsinovoy G, Strous RD. 2006. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: A randomized, double-blind, placebo controlled, crossover trial. J Clin Psychopharmacol. 26:495–499.
  • Sageman S, Brown RP. 2006. 3-acetyl-7-oxo-dehydroepiandrosterone for healing treatment-resistant posttraumatic stress disorder in women: 5 case reports. J Clin Psychiatry. 67:493–496.
  • Sapolsky RM. 2000. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry. 57:925–935.
  • Sapolsky RM. 2003. Stress and plasticity in the limbic system. Neurochem Res. 28:1735–1742.
  • Stuart-Hamilton I. 2007. Dictionary of psychological testing, assessment and treatment. London: Jessica Kingsley Publishers.
  • Taylor MK, Sausen KP, Potterat EG, Mujica-Parodi LR, Reis JR, Markham AE, Padilla GA, Taylor DL. 2007. Stressful military training: Endocrine reactivity, performance and psychological impact. Aviat Space Environ Med. 78:1143–1149.
  • Taylor MK, Mujica-Parodi LR, Padilla GA, Markham AE, Potterat EG, Momen N, Sander TC, Larson GE. 2009. Behavioral predictors of acute stress symptoms during intense military training. J Trauma Stress. 22:212–217.
  • Weiss D, Marmar C. 1997. The impact of event scale: Revised. In: Wilson J, Keane T. editors. Assessing psychological trauma and PTSD. New York: Guilford.
  • Wolkowitz OM, Reus VI, Keebler A, Nelson N, Friedland M, Brizendine L, Roberts E. 1999. Double-blind treatment of major depression with dehydroepiandrosterone (DHEA). Am J Psychiatry. 156:646–649.
  • Wolkowitz OM, Kramer JH, Reus VI, Costa MM, Yaffe K, Walton P, Raskind M, Peskind E, Newhouse P, Sack D, De Souza E, Sadowsky C, Roberts E, Alzheimer's Disease Collaborative Research. 2003. DHEA treatment of Alzheimer's disease: A randomized, double-blind, placebo-controlled study. Neurology. 60:1071–1076.
  • Yehuda R, Brand SR, Golier JA, Yang RK. 2006. Clinical correlates of DHEA associated with posttraumatic stress disorder. Acta Psychiatr Scand. 114:187–193.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.